相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CLpro
Mubarak A. Alamri et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
In silico identification of widely used and well-tolerated drugs as potential SARS-CoV-2 3C-like protease and viral RNA-dependent RNA polymerase inhibitors for direct use in clinical trials
Seref Gul et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening, molecular docking and molecular dynamics with main protease as the target
K. G. Arun et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Supervised molecular dynamics for exploring the druggability of the SARS-CoV-2 spike protein
Giuseppe Deganutti et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2021)
The tyrosine kinase inhibitor nilotinib inhibits SARS-CoV-2 in vitro
Valeria Cagno et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2021)
Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19 A Randomized Clinical Trial
Eduardo Lopez-Medina et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Bepridil is potent against SARS-CoV-2 in vitro
Erol C. Vatansever et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors
Chunlong Ma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease
Sebastian Guenther et al.
SCIENCE (2021)
Drug targets, mechanisms of drug action, and therapeutics against SARS-CoV-2
N. R. Jena
CHEMICAL PHYSICS IMPACT (2021)
Mechanism of inhibition of SARS-CoV-2 Mpro by N3 peptidyl Michael acceptor explained by QM/MM simulations and design of new derivatives with tunable chemical reactivity
Kemel Arafet et al.
CHEMICAL SCIENCE (2021)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Effect of nanoencapsulation on volatile constituents, and antioxidant and anticancer activities of Algerian Origanum glandulosum Desf. essential oil
Hatem Ali et al.
SCIENTIFIC REPORTS (2020)
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
Sangeun Jeon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19
Markus Hoffmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms
Bodee Nutho et al.
BIOCHEMISTRY (2020)
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
Linlin Zhang et al.
SCIENCE (2020)
Potential RNA-dependent RNA polymerase inhibitors as prospective therapeutics against SARS-CoV-2
Rudramani Pokhrel et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2020)
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin et al.
NATURE (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Leon Caly et al.
ANTIVIRAL RESEARCH (2020)
Tackling SARS-CoV-2: proposed targets and repurposed drugs
Siddhi Joshi et al.
FUTURE MEDICINAL CHEMISTRY (2020)
Possible SARS-coronavirus 2 inhibitor revealed by simulated molecular docking to viral main protease and host toll-like receptor
Xiaopeng Hu et al.
FUTURE VIROLOGY (2020)
Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
Chunlong Ma et al.
CELL RESEARCH (2020)
COVID-19 treatment: close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2)
Yang Song et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Computational Studies of SARS-CoV-2 3CLpro: Insights from MD Simulations
Alessandro Grottesi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Discovery of New Hydroxyethylamine Analogs against 3CLpro Protein Target of SARS-CoV-2: Molecular Docking, Molecular Dynamics Simulation, and Structure-Activity Relationship Studies
Sumit Kumar et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)
Computational Determination of Potential Inhibitors of SARS-CoV-2 Main Protease
Son Tung Ngo et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)
Structure-Based Virtual Screening to Discover Potential Lead Molecules for the SARS-CoV-2 Main Protease
Anuj Gahlawat et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)
Phytotherapeutics and SARS-CoV-2 infection: Potential role of bioflavonoids
Maurizio Coppola et al.
MEDICAL HYPOTHESES (2020)
Impact of Early Pandemic Stage Mutations on Molecular Dynamics of SARS-CoV-2 Mpro
Olivier Sheik Amamuddy et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)
Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements
Abhjieet Pandey et al.
LIFE SCIENCES (2020)
Utilizing drug repurposing against COVID-19-Efficacy, limitations, and challenges
Vineela Parvathaneni et al.
LIFE SCIENCES (2020)
Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease
Lifeng Fu et al.
NATURE COMMUNICATIONS (2020)
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease
Alice Douangamath et al.
NATURE COMMUNICATIONS (2020)
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
Wayne Vuong et al.
NATURE COMMUNICATIONS (2020)
Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2
Anamika Basu et al.
SCIENTIFIC REPORTS (2020)
Local and Global Motions Underlying Antibiotic Binding in Bacterial Ribosome
Ozge Kurkcuoglu et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)
Prediction of potential inhibitors of the dimeric SARS-CoV2 main proteinase through the MM/GBSA approach
Martiniano Bello
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2020)
Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease Inhibitors
Chunlong Ma et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
Interactive Molecular Dynamics in Virtual Reality Is an Effective Tool for Flexible Substrate and Inhibitor Docking to the SARS-CoV-2 Main Protease
Helen M. Deeks et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)
Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against Mpro and cathepsin L
Michael Dominic Sacco et al.
SCIENCE ADVANCES (2020)
Prediction of potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2 using comprehensive drug repurposing and molecular docking approach
Md Sorwer Alam Parvez et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
Identification of saquinavir as a potent inhibitor of dimeric SARS-CoV2 main protease through MM/GBSA
Martiniano Bello et al.
JOURNAL OF MOLECULAR MODELING (2020)
Antiviral agents against COVID-19: structure-based design of specific peptidomimetic inhibitors of SARS-CoV-2 main protease
Vladimir Frecer et al.
RSC ADVANCES (2020)
A comprehensive review on promising anti-viral therapeutic candidates identified against main protease from SARS-CoV-2 through various computational methods
Ekampreet Singh et al.
JOURNAL OF GENETIC ENGINEERING AND BIOTECHNOLOGY (2020)
Is hesperidin essential for prophylaxis and treatment of COVID-19 Infection?
Yusuf A. Haggag et al.
MEDICAL HYPOTHESES (2020)
Revealing the molecular mechanisms of proteolysis of SARS-CoV-2 Mpro by QM/MM computational methods
Katarzyna Swiderek et al.
CHEMICAL SCIENCE (2020)
Covalent Versus Non-covalent Enzyme Inhibition: Which Route Should We Take? A Justification of the Good and Bad from Molecular Modelling Perspective
Aimen Aljoundi et al.
PROTEIN JOURNAL (2020)
National Institute for the Infectious Diseases L. Spallanzani, IRCCS. Recommendations for COVID-19 clinical management
Emanuele Nicastri et al.
INFECTIOUS DISEASE REPORTS (2020)
Improving therapy of severe infections through drug repurposing of synergistic combinations
Yu-Shan Cheng et al.
CURRENT OPINION IN PHARMACOLOGY (2019)
Exploring allosteric communication in multiple states of the bacterial ribosome using residue network analysis
Ozge Kurkcuoglu
TURKISH JOURNAL OF BIOLOGY (2018)
Repurposing of Bromocriptine for Cancer Therapy
Ean-Jeong Seo et al.
FRONTIERS IN PHARMACOLOGY (2018)
Identification of potential allosteric communication pathways between functional sites of the bacterial ribosome by graph and elastic network models
Pelin Guzel et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2017)
Novel antiviral activity and mechanism of bromocriptine as a Zika virus NS2B-NS3 protease inhibitor
Jasper Fuk-Woo Chan et al.
ANTIVIRAL RESEARCH (2017)
Designing Irreversible InhibitorsWorth the Effort?
Concepcion Gonzalez-Bello
CHEMMEDCHEM (2016)
Novel antiviral activity of bromocriptine against dengue virus replication
Fumihiro Kato et al.
ANTIVIRAL RESEARCH (2016)
Allosteric sites: remote control in regulation of protein activity
Enrico Guarnera et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2016)
An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
Thanigaimalai Pillaiyar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Coronaviruses - drug discovery and therapeutic options
Alimuddin Zumla et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Residue Geometry Networks: A Rigidity-Based Approach to the Amino Acid Network and Evolutionary Rate Analysis
Alexander S. Fokas et al.
SCIENTIFIC REPORTS (2016)
Middle East Respiratory Syndrome Coronavirus: Another Zoonotic Betacoronavirus Causing SARS-Like Disease
Jasper F. W. Chan et al.
CLINICAL MICROBIOLOGY REVIEWS (2015)
ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB
James A. Maier et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2015)
Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection
Julie Dyall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Hot Spots in a Network of Functional Sites
Pemra Ozbek et al.
PLOS ONE (2013)
Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery
Xuan-Yu Meng et al.
Current Computer-Aided Drug Design (2012)
Drug discovery for a new generation of covalent drugs
Amit S. Kalgutkar et al.
EXPERT OPINION ON DRUG DISCOVERY (2012)
MMPBSA.py: An Efficient Program for End-State Free Energy Calculations
Bill R. Miller et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2012)
Assessing the Performance of the MM/PBSA and MM/GBSA Methods. 1. The Accuracy of Binding Free Energy Calculations Based on Molecular Dynamics Simulations
Tingjun Hou et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions
Mats H. M. Olsson et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2011)
The resurgence of covalent drugs
Juswinder Singh et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Activation and maturation of SARS-CoV main protease
Bin Xia et al.
PROTEIN & CELL (2011)
Global Dynamics of Proteins: Bridging Between Structure and Function
Ivet Bahar et al.
ANNUAL REVIEW OF BIOPHYSICS, VOL 39 (2010)
DNABINDPROT: fluctuation-based predictor of DNA-binding residues within a network of interacting residues
Pemra Ozbek et al.
NUCLEIC ACIDS RESEARCH (2010)
Antiviral and Virucidal Activities of Natural Products
Tsutomu Arakawa et al.
CURRENT MEDICINAL CHEMISTRY (2009)
The Origin of Allosteric Functional Modulation: Multiple Pre-existing Pathways
Antonio del Sol et al.
STRUCTURE (2009)
The pharmacokinetics and interactions of ivermectin in humans - A mini-review
Aranzazu Gonzalez Canga et al.
AAPS JOURNAL (2008)
Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection
Vincent C. C. Cheng et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
SARS CoV main proteinase: The monomer-dimer equilibrium dissociation constant
Vito Graziano et al.
BIOCHEMISTRY (2006)
DrugBank: a comprehensive resource for in silico drug discovery and exploration
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2006)
A network representation of protein structures: Implications for protein stability
KV Brinda et al.
BIOPHYSICAL JOURNAL (2005)
Synchronization of trajectories in canonical molecular-dynamics simulations: Observation, explanation, and exploitation
BP Uberuaga et al.
JOURNAL OF CHEMICAL PHYSICS (2004)
Unfolding events of Chymotrypsin Inhibitor 2 (CI2) revealed by Monte Carlo (MC) simulations and their consistency from structure-based analysis of conformations
SB Ozkan et al.
POLYMER (2004)
Development and testing of a general amber force field
JM Wang et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation
A Jakalian et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2002)
分享论文
